Radiopharmaceuticals - a key component of nuclear medicine

Radiopharmaceuticals are a key component of nuclear medicine, and are crucial to fighting cancer and several other medical conditions. Their use, however, requires extensive personnel training on patient safety and equipment handling.
The IAEA has supported the establishment of a new PET Centre in Skopje, through technical advice, training of professional staff and the donation of equipment.
Video: Svetlomir Slavchev
Follow IAEA on social media:
Facebook - / iaeaorg
Twitter - / iaeaorg
Google+ - plus.google.co...
Instagram - / iaeaorg
LinkedIn - / iaea
© IAEA Office of Public Information and Communication
iaea.org